Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) in the Population of the Grand Nancy Metropolitan Area

NCT04448769 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT04448769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04448769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) in the Population of the Grand Nancy Metropolitan Area
Lead sponsor
Central Hospital, Nancy, France
Phase
Not applicable
Overall status
Completed
Start date
June 26, 2020
Completion date
July 24, 2020
Enrollment
2,006 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, prevalence